drugset / Trial / NCT01579565

Safety, Efficacy and Pharmacokinetics of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification

NCT01579565

Phase 3 Completed 416 enrolled Omeros Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the safety, efficacy and pharmacokinetics of OMS302 (the study drug) for maintaining intraoperative mydriasis and preventing post operative pain in individuals undergoing Intraocular Lens Replacement (ILR) surgery.

Timeline

Start
2012-04
Primary completion
2012-11
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified Other
Subject Phenylephrine Small molecule Other

Indications

No indication recorded.